Latest Expert Opinions

Signal
Opinion
Expert
HOLD
HOLD
May 2, 2018

The stock has not done well and struggles to meet earnings expectations. Management itself became frustrated and put themselves up for strategic sale. It is worth holding to see what the reviews will be, but would not be a new buyer.

Show full opinionHide full opinion

The stock has not done well and struggles to meet earnings expectations. Management itself became frustrated and put themselves up for strategic sale. It is worth holding to see what the reviews will be, but would not be a new buyer.

HOLD
HOLD
May 2, 2018

This is a top 5 company in the pipeline group. Dividend stocks are getting hurt by the fear of rising interest rates. This is a great company with a good record of increasing dividends. This is just the wrong sector right now. He would still hold it for the long term for diversification. Yield 5.3%.

Show full opinionHide full opinion
PPL Corp (PPL-N)
May 2, 2018

This is a top 5 company in the pipeline group. Dividend stocks are getting hurt by the fear of rising interest rates. This is a great company with a good record of increasing dividends. This is just the wrong sector right now. He would still hold it for the long term for diversification. Yield 5.3%.

SPECULATIVE BUY
SPECULATIVE BUY
May 2, 2018

They do recommend it in one of their portfolios. The health monitoring business is growing and he would like to see more contracts signed. There are risks as this has a high valuation. He likes the management team. It is a speculative buy.

Show full opinionHide full opinion

They do recommend it in one of their portfolios. The health monitoring business is growing and he would like to see more contracts signed. There are risks as this has a high valuation. He likes the management team. It is a speculative buy.

DON'T BUY
DON'T BUY
May 2, 2018

This was a split-off company who struggles with a small market cap. He does not recommend this one. (Analysts’ price target is $0.35 )

Show full opinionHide full opinion

This was a split-off company who struggles with a small market cap. He does not recommend this one. (Analysts’ price target is $0.35 )

DON'T BUY
DON'T BUY
May 2, 2018

This is a cannabis company that has a new product line for pets. He generally dislikes the sector and the associated valuations. You are betting this sector is going to explode and it is hard to know which companies will survive. It has a $600 million valuation on $20 million in sales.

Show full opinionHide full opinion

This is a cannabis company that has a new product line for pets. He generally dislikes the sector and the associated valuations. You are betting this sector is going to explode and it is hard to know which companies will survive. It has a $600 million valuation on $20 million in sales.

COMMENT
COMMENT
May 2, 2018

This cannabis company has an advantage with its size. If they have started to make other acquisitions they can grow with scale. Their deal with Constellation Brands will allow them to grow internationally. Its valuation is just too high for him.

Show full opinionHide full opinion

This cannabis company has an advantage with its size. If they have started to make other acquisitions they can grow with scale. Their deal with Constellation Brands will allow them to grow internationally. Its valuation is just too high for him.

DON'T BUY
DON'T BUY
May 2, 2018

Costs are going up and revenues are going down. They have done many stock issues and not rewarded their investors. When production forecasts fall short of expectations investors will go elsewhere.

Show full opinionHide full opinion

Costs are going up and revenues are going down. They have done many stock issues and not rewarded their investors. When production forecasts fall short of expectations investors will go elsewhere.